Real-World Evidence Strategy Lead, Respiratory (Hybrid)

UCB

Brussel

Hybrid

EUR 165,000 - 216,000

Full time

15 hours ago
Be an early applicant

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

UCB is seeking a Real-World Evidence Strategy Lead, Respiratory, to drive global evidence strategies across the lifecycle of respiratory assets. This hybrid, results-driven role collaborates across clinical development, regulatory, market access and safety to inform decisions that improve patient outcomes.

The candidate will translate research questions into evidence plans, lead studies with governance and budget oversight, and mentor a global team.

Qualifications

  • Advanced degree in life sciences, medicine, epidemiology, statistics, or related discipline.
  • At least eight years of pharmaceutical industry experience, ideally within respiratory medicine or immunology.
  • Strong expertise in epidemiology, outcomes research, clinical development, regulation, and market access.
  • Proven ability to lead cross-functional teams and mentor colleagues.

Responsibilities

  • Develop integrated real-world evidence strategies supporting respiratory assets throughout their lifecycle.
  • Translate stakeholder research questions into impactful data, registry, and evidence-generation plans.
  • Lead real-world evidence studies, ensuring quality, governance, timelines, and budget adherence.
  • Collaborate across functions to align evidence priorities and resolve competing stakeholder needs.
  • Build relationships with external experts, research partners, and healthcare decision-makers.
  • Mentor evidence-generation professionals and support capability development across the global function.

Skills

Advanced degree
8+ years exp
Respiratory/immunology
Epidemiology
Outcomes research
Regulatory/market access
Cross-functional leadership
Scientific writing
Quantitative analysis

Education

Advanced degree in life sciences
Epidemiology or statistics

Job description

UCB is seeking a Real-World Evidence Strategy Lead, Respiratory, to drive global evidence strategies across the lifecycle of respiratory assets. This hybrid, results-driven role collaborates across clinical development, regulatory, market access and safety to inform decisions that improve patient outcomes.

The candidate will translate research questions into evidence plans, lead studies with governance and budget oversight, and mentor a global team.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

RWE Strategy Lead Respiratory
RWE Strategy Lead Respiratory

UCB • Brussel

Hybrid
EUR 165,000 - 216,000
Senior Real-World Evidence Lead, Special Populations
Senior Real-World Evidence Lead, Special Populations

UCB • Anderlecht

Hybrid
EUR 90,000 - 130,000
Global RWE Strategy Leader, Immunology
Global RWE Strategy Leader, Immunology

UCB • Brussel

Hybrid
EUR 110,000 - 140,000
Hybrid work model
Global exposure
RWE Strategy Lead, Developed Brands (BE)
RWE Strategy Lead, Developed Brands (BE)

UCB • Brussel

Hybrid
EUR 110,000 - 140,000
Hybrid work model
Global exposure
Director, Global Respiratory Epidemiology & RWE
Director, Global Respiratory Epidemiology & RWE

GSK • Waver

Hybrid
EUR 123,000 - 205,000
Global Medical Evidence Strategy Lead
Global Medical Evidence Strategy Lead

UCB • Brussel

Hybrid
EUR 120,000 - 170,000
Hybrid work model
Senior RWE Strategy Lead - Dermatology
Senior RWE Strategy Lead - Dermatology

Pauwels Consulting • Eigenbrakel

On-site
EUR 120,000 - 180,000
Global HEOR Strategy Lead: Payer Evidence & Value
Global HEOR Strategy Lead: Payer Evidence & Value

UCB S.A. • Anderlecht

Hybrid
EUR 120,000 - 165,000
Senior RWE Lead - Special Patient Populations
Senior RWE Lead - Special Patient Populations

UCB • Belgium

Hybrid
USD 140,000 - 190,000
Hybrid work model
RWE Senior Expert - Special Patient Populations
RWE Senior Expert - Special Patient Populations

UCB • Belgium

On-site
USD 140,000 - 190,000
Hybrid work model